Total Payments
$5,762
2024 Payments
$346.87
Companies
32
Transactions
431
Medicare Patients
1,404
Medicare Billing
$115,803
Payment Breakdown by Category
Food & Beverage$5,762 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,762 | 431 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,429 | 67 | $0 (2024) |
| PFIZER INC. | $1,162 | 107 | $0 (2024) |
| Novo Nordisk Inc | $480.52 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $343.82 | 27 | $0 (2023) |
| Daiichi Sankyo Inc. | $242.02 | 24 | $0 (2021) |
| Amgen Inc. | $232.63 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $207.80 | 12 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $178.64 | 21 | $0 (2021) |
| Allergan Inc. | $163.74 | 18 | $0 (2017) |
| ABBVIE INC. | $146.06 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $346.87 | 20 | ABBVIE INC. ($98.60) |
| 2023 | $431.55 | 27 | AstraZeneca Pharmaceuticals LP ($98.91) |
| 2022 | $366.46 | 21 | AstraZeneca Pharmaceuticals LP ($137.64) |
| 2021 | $285.40 | 21 | AstraZeneca Pharmaceuticals LP ($65.73) |
| 2020 | $123.95 | 9 | Novo Nordisk Inc ($27.58) |
| 2019 | $1,602 | 112 | AstraZeneca Pharmaceuticals LP ($416.19) |
| 2018 | $1,150 | 85 | PFIZER INC. ($355.85) |
| 2017 | $1,456 | 136 | PFIZER INC. ($315.25) |
All Payment Transactions
431 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: PAIN | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PAIN | ||||||
| 04/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Cardiovascular | ||||||
| 04/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Inflammation | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Respiratory | ||||||
| 02/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 02/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: PAIN | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 01/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Diabetes | ||||||
| 12/29/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Inflammation | ||||||
| 11/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: DIABETES | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 318 | 759 | $50,319 | $25,827 |
| 2022 | 9 | 367 | 904 | $63,999 | $31,242 |
| 2021 | 6 | 307 | 823 | $56,110 | $28,160 |
| 2020 | 10 | 412 | 1,066 | $71,441 | $30,574 |
Total Patients
1,404
Total Services
3,552
Medicare Billing
$115,803
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 416 | $43,680 | $22,063 | 50.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 97 | 226 | $2,260 | $1,887 | 83.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 28 | 28 | $1,260 | $888.16 | 70.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $652.00 | $528.64 | 81.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 24 | $912.00 | $233.42 | 25.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $1,275 | $130.80 | 10.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 28 | $280.00 | $95.48 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 458 | $48,090 | $25,656 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $5,175 | $1,920 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,575 | $1,219 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 114 | 288 | $2,880 | $852.78 | 29.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 28 | 28 | $1,240 | $833.69 | 67.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 29 | $742.00 | $294.82 | 39.7% |
| 90471 | Administration of vaccine | Office | 2022 | 20 | 20 | $742.00 | $226.62 | 30.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 17 | $1,275 | $142.38 | 11.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 28 | $280.00 | $95.89 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 460 | $48,300 | $25,783 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 13 | $2,925 | $1,033 | 35.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 118 | 286 | $2,860 | $858.00 | 30.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 28 | $560.00 | $258.98 | 46.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 17 | $1,275 | $160.58 | 12.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 19 | $190.00 | $66.12 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 135 | 564 | $57,296 | $25,649 | 44.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 30 | $6,590 | $2,196 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 122 | 292 | $2,920 | $870.60 | 29.8% |
About Dr. Phillip Malvasi, DO
Dr. Phillip Malvasi, DO is a Family Medicine healthcare provider based in Niles, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376690438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phillip Malvasi, DO has received a total of $5,762 in payments from pharmaceutical and medical device companies, with $346.87 received in 2024. These payments were reported across 431 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,762).
As a Medicare-enrolled provider, Malvasi has provided services to 1,404 Medicare beneficiaries, totaling 3,552 services with total Medicare billing of $115,803. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Niles, OH
- Active Since 01/04/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376690438
Products in Payments
- FARXIGA (Drug) $916.55
- CHANTIX (Drug) $473.12
- ELIQUIS (Drug) $262.01
- BEVESPI AEROSPHERE (Drug) $240.99
- EUCRISA (Drug) $218.90
- Ozempic (Drug) $208.30
- Vascepa (Drug) $207.80
- TRADJENTA (Drug) $163.03
- VRAYLAR (Drug) $162.77
- Welchol (Drug) $158.49
- XARELTO (Drug) $142.59
- BREZTRI (Drug) $132.79
- LYRICA (Drug) $132.59
- Victoza (Drug) $131.73
- VIAGRA (Drug) $121.66
- JANUVIA (Drug) $118.30
- Livalo (Drug) $113.37
- Otezla (Drug) $106.95
- JARDIANCE (Drug) $105.29
- NURTEC ODT (Drug) $101.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Niles
Dr. Brad Ferrari, Md, MD
Family Medicine — Payments: $9,581
Family Medicine $9,581
John Howard, M.d, M.D
Family Medicine — Payments: $9,095
Family Medicine $9,095
Tracy Tacket, Do, DO
Family Medicine — Payments: $5,812
Family Medicine $5,812
Elizabeth Mcglothlin, M.d, M.D
Family Medicine — Payments: $4,955
Family Medicine $4,955
Dr. Shannon Twiddy, M.d, M.D
Family Medicine — Payments: $4,344
Family Medicine $4,344
Raul Torres, D.o, D.O
Family Medicine — Payments: $4,075
Family Medicine $4,075